Indoor Air Quality Monitor for Smoking Cessation
Trial Summary
What is the purpose of this trial?
The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program.
Do I need to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It focuses on using an air quality monitor to help quit smoking, so it's best to ask the trial coordinators for more details.
What data supports the effectiveness of the treatment Indoor Air Quality Monitor AirGradient ONE for smoking cessation?
Research shows that using air quality monitors and air cleaners can help reduce indoor air pollution, which has been linked to better respiratory health. In a study, air cleaners improved symptoms in people with chronic obstructive pulmonary disease (COPD), suggesting that improving indoor air quality might also support smoking cessation efforts by highlighting the impact of smoking on air quality.12345
Is the Indoor Air Quality Monitor for Smoking Cessation safe for humans?
The research articles do not provide specific safety data for the Indoor Air Quality Monitor for Smoking Cessation or its related models. However, they discuss the use of air quality monitors in general, which are used to measure indoor air pollution from smoking, and there are no reported safety concerns related to the monitors themselves.36789
How does the Indoor Air Quality Monitor for Smoking Cessation differ from other treatments for smoking cessation?
The Indoor Air Quality Monitor for Smoking Cessation is unique because it uses a device to measure carbon monoxide levels in the air, helping individuals track their smoking habits in real-time. Unlike traditional methods that rely on self-reporting or standalone devices, this approach provides continuous, objective feedback, potentially increasing awareness and motivation to quit smoking.1011121314
Research Team
Jamie Ostroff, PhD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Eligibility Criteria
This trial is for cancer patients trying to quit smoking and are enrolled in MSK's Tobacco Treatment Program. It aims to see if using an air quality monitor helps them keep their homes smoke-free.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use an indoor air quality monitor and attend smoke-free workshop sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Indoor Air Quality Monitor AirGradient ONE (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
Lisa M. DeAngelis
Memorial Sloan Kettering Cancer Center
Chief Medical Officer since 2021
MD from Columbia University
Selwyn M. Vickers
Memorial Sloan Kettering Cancer Center
Chief Executive Officer since 2022
MD from Johns Hopkins University